Hepatitis-C Drugs And A Remdesivir Metabolite As New Anti-Covid-19 Drugs: The Viral Protein NSP3 Emerges As A New Target. In the search for new ways to use small molecule drugs to prevent and treat Covid-19 infections, a surprising synergy has emerged. Two drugs hold immediate promise for prevention and treatment of infection by SARS-CoV-2.